Bioray Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Bioray Biotech has a total shareholder equity of NT$417.0M and total debt of NT$35.0M, which brings its debt-to-equity ratio to 8.4%. Its total assets and total liabilities are NT$550.1M and NT$133.1M respectively.
Key information
8.4%
Debt to equity ratio
NT$35.00m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$140.55m |
| Equity | NT$416.97m |
| Total liabilities | NT$133.10m |
| Total assets | NT$550.06m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 7561's short term assets (NT$292.5M) exceed its short term liabilities (NT$87.0M).
Long Term Liabilities: 7561's short term assets (NT$292.5M) exceed its long term liabilities (NT$46.1M).
Debt to Equity History and Analysis
Debt Level: 7561 has more cash than its total debt.
Reducing Debt: 7561's debt to equity ratio has increased from 0% to 8.4% over the past 5 years.
Debt Coverage: 7561's debt is not well covered by operating cash flow (18.4%).
Interest Coverage: Insufficient data to determine if 7561's interest payments on its debt are well covered by EBIT.